3861 results for «2549»

Filter By

3861 results

Shock the Rock: new intravascular lithotripsy real-world data and cases

18 May 2021 – From EuroPCR 2021

Watch this session presented by Emanuele Barbato, Holger Nef, Arif Al Nooryani, Alfonso Ielasi, Michael Haude, Margaret McEntegart and Flavio Luciano Ribichini in order to learn how to optimally adopt Intravascular Lithotripsy (IVL) for treatment of calcified lesions, to identify best practices when using IVL in different clinical settings,...

Shock the Rock: new intravascular lithotripsy real-world data and cases

How CT fusion can empower your structural heart procedures

18 May 2021 – From EuroPCR 2021

Watch this session presented by Thomas Modine, Erwan Donal, Julia Grapsa and Ronak Rajani in order to learn how the novel tools in 4D TEE can help improving visualisation, navigation and communication within the heart team and how to better plan your structural heart procedures with Echo...

How CT fusion can empower your structural heart procedures

Revisiting T and TAP: key steps and pitfalls

18 May 2021 – From EuroPCR 2021

Watch this session if you want to learn the steps of T and TAP (T and Protrusion), to review the potential pitfalls of T and TAP (T and Protrusion) and to understand the limitations of angiography to accurately assess stent geometry at different steps of the...

Revisiting T and TAP: key steps and pitfalls

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

The new Evolut PRO+ system: optimal procedural outcomes in all patients

20 May 2021 – From EuroPCR 2021

Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...

The new Evolut PRO+ system: optimal procedural outcomes in all patients

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

20 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

Planning for a long run: life-time management of bioprosthetic valve implantation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan Windecker, Anna Sonia Petronio, Mohamed Abdel-Wahab, Lars Sondergaard and Hendrik Treede in order to learn about life-time management strategies of aortic stenosis patients, to discuss evolving multifactorial aspects that influence the choice of aortic stenosis patient treatment, and to explore THV...

Planning for a long run: life-time management of bioprosthetic valve implantation

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

Advances in investigational mitral and tricuspid therapies

18 May 2021 – From EuroPCR 2021

Watch this session presented by Lars Sondergaard, Vinayak Bapat, Thomas Modine, Firas Zahr and Azeem Latib in order to see a review of the Medtronic TMVR/TTVR EFS studies and system, to review one mitral EFS case and one tricuspid EFS case, and to discuss future of TMVR/TTVR in...

Advances in investigational mitral and tricuspid therapies

Where deliverability matters: challenging cases requiring a low profile

18 May 2021 – From EuroPCR 2021

Watch this session presented by Robert Byrne, Ralph Toelg, Stefano Galli, Farrel Hellig and Jack Tan in order to participate in interactive reviews of interesting DES, DCB and covered stent cases and outcomes, to assess where ultrathin DES, DCB and covered stent provide a clinical benefit, and to...

Where deliverability matters: challenging cases requiring a low profile

PCI of calcified coronaries - we will rock you! - Part 3

18 May 2021 – From EuroPCR 2021

Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for IntraVascular Lithotripsy.

This session was originally presented during EuroPCR 2021.

PCI of calcified coronaries - we will rock you! - Part 3

Transcatheter mitral valve replacement and repair: why do we need both

18 May 2021 – From EuroPCR 2021

Watch this session presented by Michael Borger, Nicolas Dumonteil, Paolo Denti, Lenard Conradi, Hendrik Treed and Ralph von Bardeleben in order to learn about the expanded treatment options and latest innovations in transcatheter mitral valve therapies, and to tailor your treatment options to optimise patient outcomes with...

Transcatheter mitral valve replacement and repair: why do we need both

Complex PCI in coronary calcified lesions, the right tools and techniques

18 May 2021 – From EuroPCR 2021

Watch this session presented by Flavio Luciano Ribichini, Colm Hanratty, Mark Kennedy, Emile Mehanna, David Leistner and Akiko Maehara in order to learn practical tips to assess calcified lesions with IVUS, to discuss the device selection for calcium treatment to improve patient outcome, and to know more about SYNERGY MEGATRON,...

Complex PCI in coronary calcified lesions, the right tools and techniques

Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.

This session was originally presented...

Revascularisation for chronic coronary syndrome and multivessel disease - Part 1

Below the knee (BTK) angioplasty - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to review indications, treatment strategies and equipment, to discuss LIVE procedures and to appreciate the similaritites between coronary and BTK interventions.

This session was originally presented during EuroPCR 2021.

Below the knee (BTK) angioplasty

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

18 May 2021 – From EuroPCR 2021

Watch this session if you want to  understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.

This session was originally presented during EuroPCR 2021.

Revascularisation for chronic coronary syndrome and multivessel disease - Part 2

Multivessel disease revascularisation: balancing the risk

19 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...

Multivessel disease revascularisation: balancing the risk

Challenges and opportunities in high-risk patients undergoing TAVI

19 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation

Challenges and opportunities in high-risk patients undergoing TAVI

EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in bifurcation lesions:

  • EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
  • Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!

SFA and popliteal interventions (part 1) - Session with LIVE demonstration

18 May 2021 – From EuroPCR 2021

Watch this session if you want to review indications, treatment strategies and equipment and to discuss LIVE procedures.

This session was originally presented during EuroPCR 2021.

SFA and popliteal interventions
Didn’t find what you were looking for?